Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen S Atkins

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Infection and Immunity|May 23, 2006
The ABC transporter protein OppA provides protection against experimental Yersinia pestis infectionMikio Tanabe, Helen S Atkins, David N Harland, et al.
Microbial Pathogenesis|June 7, 2011
Yersinia pestis TIR-domain protein forms dimers that interact with the human adaptor protein MyD88Rohini R Rana, Peter Simpson, Minghao Zhang, et al.
European Journal of Immunology|December 25, 2010
CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosisKaren K Chu, Patcharaporn Tippayawat, Nicola J Walker, et al.
International Journal of Antimicrobial Agents|December 22, 2009
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infectionHelen S Atkins, Stephen Spencer, Simon D Brew, et al.
International Journal of Antimicrobial Agents|August 18, 2009
Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infectionHelen S Atkins, Stephen Spencer, Simon D Brew, et al.
International Journal of Antimicrobial Agents|November 12, 2013
CpG oligonucleotides protect against Venezuelan equine encephalitis virus infection in a route-dependent mannerD G Cerys Rees, Robert J Phillpotts, Kate F Griffin, et al.
Microbial Pathogenesis|May 28, 2013
The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assaysD G Cerys Rees, M Gill Hartley, Michael Green, et al.
Biochemistry and Biophysics Reports|June 18, 2020
Identification and analysis of novel small molecule inhibitors of RNase E: Implications for antibacterial targeting and regulation of RNase ECharlotte E Mardle, Layla R Goddard, Bailei C Spelman, et al.
Microbiology (Reading, England)|March 10, 2012
A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plagueAbigail M Spear, Rohini R Rana, Dominic C Jenner, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2014
Liposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4Karleigh A Hamblin, Stuart J Armstrong, Kay B Barnes, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Infection and Immunity|May 23, 2006
The ABC transporter protein OppA provides protection against experimental Yersinia pestis infectionMikio Tanabe, Helen S Atkins, David N Harland, et al.
Microbial Pathogenesis|June 7, 2011
Yersinia pestis TIR-domain protein forms dimers that interact with the human adaptor protein MyD88Rohini R Rana, Peter Simpson, Minghao Zhang, et al.
European Journal of Immunology|December 25, 2010
CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosisKaren K Chu, Patcharaporn Tippayawat, Nicola J Walker, et al.
International Journal of Antimicrobial Agents|December 22, 2009
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infectionHelen S Atkins, Stephen Spencer, Simon D Brew, et al.
International Journal of Antimicrobial Agents|August 18, 2009
Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infectionHelen S Atkins, Stephen Spencer, Simon D Brew, et al.
International Journal of Antimicrobial Agents|November 12, 2013
CpG oligonucleotides protect against Venezuelan equine encephalitis virus infection in a route-dependent mannerD G Cerys Rees, Robert J Phillpotts, Kate F Griffin, et al.
Microbial Pathogenesis|May 28, 2013
The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assaysD G Cerys Rees, M Gill Hartley, Michael Green, et al.
Biochemistry and Biophysics Reports|June 18, 2020
Identification and analysis of novel small molecule inhibitors of RNase E: Implications for antibacterial targeting and regulation of RNase ECharlotte E Mardle, Layla R Goddard, Bailei C Spelman, et al.
Microbiology (Reading, England)|March 10, 2012
A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plagueAbigail M Spear, Rohini R Rana, Dominic C Jenner, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2014
Liposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4Karleigh A Hamblin, Stuart J Armstrong, Kay B Barnes, et al.
Pageof 7